6483 Stock Overview
A biotechnology company, chemical entities to solve unmet medical needs in Taiwan. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Original BioMedicals Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$11.55 |
| 52 Week High | NT$28.00 |
| 52 Week Low | NT$9.99 |
| Beta | 0.058 |
| 1 Month Change | -0.43% |
| 3 Month Change | -17.20% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -86.08% |
Recent News & Updates
Recent updates
Shareholder Returns
| 6483 | TW Biotechs | TW Market | |
|---|---|---|---|
| 7D | 11.6% | 4.2% | -0.7% |
| 1Y | n/a | 17.7% | 26.3% |
Return vs Industry: Insufficient data to determine how 6483 performed against the TW Biotechs industry.
Return vs Market: Insufficient data to determine how 6483 performed against the TW Market.
Price Volatility
| 6483 volatility | |
|---|---|
| 6483 Average Weekly Movement | 7.0% |
| Biotechs Industry Average Movement | 5.2% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in TW Market | 8.0% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 6483's share price has been volatile over the past 3 months compared to the TW market.
Volatility Over Time: 6483's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of TW stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 20 | Cliff Wang | www.i-obm.com/English_Version/index.aspx |
Original BioMedicals Co., Ltd., a biotechnology company, chemical entities to solve unmet medical needs in Taiwan. It develops (A01) Radprotect, a pre-clinical product to protects against radiation exposer; (A02) CCM-Ami, which protects normal tissues from the toxic effects of chemotherapeutic agents and ionizing radiation; and ((P01)GLP-1 CCM for the treatment of type 2 diabetes. The company was founded in 2011 and is based in Taipei, Taiwan.
Original BioMedicals Co., Ltd. Fundamentals Summary
| 6483 fundamental statistics | |
|---|---|
| Market cap | NT$775.41m |
| Earnings (TTM) | -NT$71.50m |
| Revenue (TTM) | NT$43.00k |
Over9,999x
P/S Ratio-10.7x
P/E RatioIs 6483 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6483 income statement (TTM) | |
|---|---|
| Revenue | NT$43.00k |
| Cost of Revenue | NT$8.00k |
| Gross Profit | NT$35.00k |
| Other Expenses | NT$71.53m |
| Earnings | -NT$71.50m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.08 |
| Gross Margin | 81.40% |
| Net Profit Margin | -166,269.77% |
| Debt/Equity Ratio | 0% |
How did 6483 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/07 11:21 |
| End of Day Share Price | 2025/02/07 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Original BioMedicals Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.